SCHEMBL12294934

SCHEMBL12294934

C#CCCCC(=O)NCCCCC(NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CCCC#C)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 6/20 0.51
▸ PSEN2 P49810 6/20 0.51
▸ APH1B Q8WW43 6/20 0.51
▸ NCSTN Q92542 6/20 0.51
▸ APH1A Q96BI3 6/20 0.51
▸ PSENEN Q9NZ42 6/20 0.51
▸ OPRM1 P35372 3/20 0.49
▸ OPRD1 P41143 3/20 0.49
▸ OPRK1 P41145 3/20 0.49
▸ CTSB P07858 1/20 0.49
▸ KISS1R Q969F8 1/20 0.46
▸ CAPN1 P07384 1/20 0.45
▸ CAPN2 P17655 1/20 0.45
▸ NPBWR1 P48145 2/20 0.44
▸ NPY1R P25929 1/20 0.44
▸ NPY2R P49146 1/20 0.44
▸ NPY4R P50391 1/20 0.44
▸ NPY5R Q15761 1/20 0.44
▸ FOLH1 Q04609 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12294937 0.89 PSEN1 (0.50) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL12294941 0.86 REN (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL12294935 0.80 FAAH (0.50) —
SCHEMBL29389760 0.79 OPRK1 (0.57) OPRM1OPRD1OPRK1CTSB
SCHEMBL30434531 0.79 OPRK1 (0.56) OPRM1OPRD1OPRK1CTSB
SCHEMBL29569557 0.79 OPRK1 (0.56) OPRM1OPRD1OPRK1CTSB
SCHEMBL15004075 0.78 KISS1R (0.47) OPRM1OPRD1OPRK1CTSBKISS1R
SCHEMBL29568812 0.78 OPRK1 (0.55) OPRM1OPRD1OPRK1CTSB
SCHEMBL13033364 0.78 CAPN1 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL31236826 0.78 OPRK1 (0.62) OPRM1OPRD1OPRK1CTSBNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2544701-B1 POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF UNIV UTAH RES FOUND (US) 2019-08-14 — — EP disclosed
US-9289510-B2 Polymeric drug delivery conjugates and methods of making and using thereof UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2016-03-22 — — US disclosed
US-20130156722-A1 POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2013-06-20 — — US disclosed
WO-2011112482-A2 POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2011-09-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130156722-A1 POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF CD44, MMP7, MMP26 PSEN1 3954/4885PSEN2 4131/4885APH1B 2903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback